FAKTOR-OPTIONSSCHEIN - MEDTRONIC Share Price

Certificat

DE000SD41841

Real-time Boerse Frankfurt Warrants 13:27:58 27/06/2024 BST
10.67 EUR -0.74% Intraday chart for FAKTOR-OPTIONSSCHEIN - MEDTRONIC
Current month+4.67%
1 month+9.25%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
27/06/24 10.67 -0.74%
26/06/24 10.75 +0.84%
25/06/24 10.66 +3.29%
24/06/24 10.32 +1.78%
21/06/24 10.14 -4.52%

Real-time Boerse Frankfurt Warrants

Last update June 27, 2024 at 01:27 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SD4184
ISINDE000SD41841
Date issued 29/03/2021
Strike 116.7 $
Maturity Unlimited
Parity 1 : 1
Emission price 8.48
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 18.56
Lowest since issue 5.07
Spread 0.13
Spread %1.20%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
80.05 USD
Average target price
94.02 USD
Spread / Average Target
+17.46%
Consensus